- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 13/00 - Drugs for disorders of the urinary system
Patent holdings for IPC class A61P 13/00
Total number of patents in this class: 956
10-year publication summary
|
45
|
37
|
43
|
58
|
65
|
83
|
58
|
71
|
40
|
13
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer AG | 3299 |
23 |
| Allergan, Inc. | 2362 |
20 |
| F. Hoffmann-La Roche AG | 7926 |
18 |
| Bayer Pharma AG | 1061 |
18 |
| Astellas Pharma Inc. | 1086 |
17 |
| Janssen Pharmaceutica N.V. | 3423 |
14 |
| Takeda Pharmaceutical Company Limited | 2704 |
12 |
| Shionogi & Co., Ltd. | 867 |
11 |
| Ranbaxy Laboratories Limited | 319 |
9 |
| Santa Farma İlaç Sanayi̇ A.ş. | 54 |
9 |
| Novartis AG | 10904 |
8 |
| Boehringer Ingelheim International GmbH | 4704 |
8 |
| sanofi-aventis | 374 |
7 |
| AstraZeneca AB | 2928 |
6 |
| Janssen Pharmaceuticals, Inc. | 428 |
6 |
| Bayer Healthcare AG | 101 |
6 |
| Vertex Pharmaceuticals Incorporated | 1596 |
6 |
| Angion Biomedica Corp. | 61 |
6 |
| Bristol-myers Squibb Company | 4892 |
5 |
| Merck Patent GmbH | 5850 |
5 |
| Other owners | 742 |